These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29561294)

  • 41. Hepatitis C infection among drug users in northern Thailand.
    Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
    Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection.
    Ghosn J; Deveau C; Goujard C; Garrigue I; Saïchi N; Galimand J; Nagy Z; Rouzioux C; Meyer L; Chaix ML
    Sex Transm Infect; 2006 Dec; 82(6):458-60. PubMed ID: 16923739
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross sectional study of factors associated to self-reported blood-borne infections among drug users.
    Reyes-Urueña J; Brugal MT; Majo X; Domingo-Salvany A; Caylà JA
    BMC Public Health; 2015 Nov; 15():1122. PubMed ID: 26566634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users.
    Neaigus A; Gyarmathy VA; Zhao M; Miller M; Friedman SR; Des Jarlais DC
    J Infect Dis; 2007 Apr; 195(7):1052-61. PubMed ID: 17330797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
    Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High hepatitis C incidence in new injecting drug users: a policy failure?
    Maher L; Li J; Jalaludin B; Chant KG; Kaldor JM
    Aust N Z J Public Health; 2007 Feb; 31(1):30-5. PubMed ID: 17333606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methadone maintenance treatment and HIV type 1 seroconversion among injecting drug users.
    Williams AB; McNelly EA; Williams AE; D'Aquila RT
    AIDS Care; 1992; 4(1):35-41. PubMed ID: 1314099
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differences in access to care among injection drug users infected either with HIV and hepatitis C or hepatitis C alone.
    Braitstein P; Li K; Kerr T; Montaner JS; Hogg RS; Wood E
    AIDS Care; 2006 Oct; 18(7):690-3. PubMed ID: 16971276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users.
    Hernandez-Aguado I; Ramos-Rincon JM; Aviñio MJ; Gonzalez-Aracil J; Pérez-Hoyos S; de la Hera MG;
    Eur J Epidemiol; 2001; 17(6):539-44. PubMed ID: 11949726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada.
    Roy E; Richer I; Morissette C; Leclerc P; Parent R; Claessens C; Blanchette C; Alary M
    AIDS; 2011 Sep; 25(15):1897-903. PubMed ID: 21785319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs.
    Young SV; Wood E; Dong H; Kerr T; Hayashi K
    Addiction; 2016 Aug; 111(8):1360-5. PubMed ID: 26639363
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.
    Santana Rodríguez OE; Malé Gil ML; HernándezSantana JF; Limiñana Cañal JM; Martín Sánchez AM
    Eur J Epidemiol; 1998 Sep; 14(6):555-61. PubMed ID: 9794122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study.
    Dorrucci M; Rezza G; Vlahov D; Pezzotti P; Sinicco A; Nicolosi A; Lazzarin A; Galai N; Gafà S; Pristerà R
    AIDS; 1995 Jun; 9(6):597-604. PubMed ID: 7662199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatitis C virus reinfection in injection drug users.
    Grebely J; Conway B; Raffa JD; Lai C; Krajden M; Tyndall MW
    Hepatology; 2006 Nov; 44(5):1139-45. PubMed ID: 17058216
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.
    Peters L; Mocroft A; Soriano V; Rockstroh JK; Kirkby N; Reiss P; Katlama C; Zakharova N; Flisiak R; Lundgren JD;
    HIV Med; 2014 Nov; 15(10):615-20. PubMed ID: 24814468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients.
    Peters L; Grint D; Lundgren JD; Rockstroh JK; Soriano V; Reiss P; Grzeszczuk A; Sambatakou H; Mocroft A; Kirk O;
    AIDS; 2012 Sep; 26(15):1917-26. PubMed ID: 22781222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia.
    Jin F; Prestage GP; Matthews G; Zablotska I; Rawstorne P; Kippax SC; Kaldor JM; Grulich AE
    Sex Transm Infect; 2010 Feb; 86(1):25-8. PubMed ID: 19841001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical symptoms associated with seroconversion for HIV-1 among misusers of intravenous drugs: comparison with homosexual seroconverters and infected and non-infected intravenous drug misusers.
    Mientjes GH; van Ameijden EJ; Weigel HM; van den Hoek JA; Coutinho RA
    BMJ; 1993 Feb; 306(6874):371-3. PubMed ID: 8461683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.